Apposite Capital is a London-based investment firm focused on healthcare services and life sciences companies.
Business Model:
Revenue: $9.9M
Employees: 2-10
Address: Bracken House
City: London
State: england
Zip: EC4M 9JA
Country: GB
Apposite Capital solely focuses on healthcare. They work closely with management teams; providing operational support and strategic guidance as much as capital to together build market leading companies. They invest in high potential revenue-generating companies across Europe. They tailor their investment to each company’s needs and consider all types of financing structures (minority, growth, buyout, buyin, etc). They typically seek to invest £10-20 million over the life of each investment but an initial investment can be £5 million or less.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2012 | Ambit Biosciences | Venture Round | 0 |
6/2011 | Ambit Biosciences | Series D | 0 |
7/2006 | Ambrx | Series C | 52M |
2/2011 | Ulthera | Series C | 10.5M |
11/2007 | Ambit Biosciences | Series D | 49.3M |
5/2016 | Medical Imaging Partnership | Venture Round | 0 |
1/2019 | Riverdale Healthcare | Private Equity Round | - |
6/2007 | Serentis | Series A | 20.5M |
6/2022 | Mirada Medical | Private Equity Round | 0 |
11/2006 | PharmaKodex | Series A | 13.5M |
1/2009 | Anaphore | Series A | 25M |
6/2009 | Anaphore | Series A | 13M |
4/2019 | Mirada Medical | Private Equity Round | 0 |
8/2008 | Serentis | Series A | 10.1M |
3/2014 | Bird Rock Bio | Series B | 0 |
1/2009 | Bird Rock Bio | Series A | 25M |
12/2013 | Cancer Partners UK | Venture Round | - |
5/2017 | NIMGenetics | Venture Round | 0 |
10/2010 | Convergence Pharmaceuticals | Series A | 35.4M |
6/2022 | Mirada Medical | Private Equity Round | 0 |
4/2019 | Mirada Medical | Private Equity Round | 0 |
1/2019 | Riverdale Healthcare | Private Equity Round | - |
5/2017 | NIMGenetics | Venture Round | 0 |
5/2016 | Medical Imaging Partnership | Venture Round | 0 |
3/2014 | Bird Rock Bio | Series B | 0 |
12/2013 | Cancer Partners UK | Venture Round | - |
11/2012 | Ambit Biosciences | Venture Round | 0 |
6/2011 | Ambit Biosciences | Series D | 0 |
2/2011 | Ulthera | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|